IL10 and COVID-19: Taken together, COVID-19 is characterized by a more consistent increase in blood IL-10 across the age groups of patients and an earlier onset of its increase than seen for other blood cytokines, as well as a possibly similar increase in stable and critical illness and a slow decline following symptom onset.